A recent study has reported that supramolecular nanoassemblies of salmon calcitonin and aspartame have a good osteoinductive capacity, providing a convenient alternative strategy for osteoporosis therapy (31), and aspartame was confirmed to improve the biocompatibility and pharmacodynamics of salmon calcitonin. Here, CALCA is linked to osteoporosis.